Related Experiment Videos

Mifepristone (RU 486)--a modulator of progestin and glucocorticoid action

I M Spitz¹, C W Bardin

¹Center for Biomedical Research, Population Council, New York, NY 10021.

The New England Journal of Medicine

|August 5, 1993

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonists.

Prostate cancer and prostatic diseases·2008

Estradiol/progesterone-releasing vaginal rings for hormone replacement therapy in postmenopausal women.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2003

Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis.

Human reproduction (Oxford, England)·2003

Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders.

Human reproduction (Oxford, England)·2002

Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.

Human reproduction (Oxford, England)·2001

Effective long-term androgen suppression in men with prostate cancer using a hydrogel implant with the GnRH agonist histrelin.

Urology·2001

See all related articles